Clinical Trials
- Heart/Cardiovascular
Botox type A for the prevention of POAF in open-chest cardiac surgery
- Ages55 years - 90 years
- GenderBoth
- Heart/Cardiovascular
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- Ages1 year - 70 years
- GenderBoth
- Heart/Cardiovascular
Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG (PACES)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
- Ages18 years and older
- GenderBoth